micafungin and Liver-Cirrhosis--Alcoholic

micafungin has been researched along with Liver-Cirrhosis--Alcoholic* in 1 studies

Other Studies

1 other study(ies) available for micafungin and Liver-Cirrhosis--Alcoholic

ArticleYear
A case of drug-induced myopathy in alcoholic cirrhosis caused by voriconazole.
    European review for medical and pharmacological sciences, 2023, Volume: 27, Issue:9

    Voriconazole is a new generation of broad-spectrum antifungal agents commonly used in the treatment of invasive aspergillus infections.. We reported a rare case of myopathy induced by voriconazole, which showed severe muscle pain and significantly elevated myocardial enzymes. Enzymes eventually achieved good efficacy by switching voriconazole to micafungin and the use of L-carnitine.. This reminded us it was necessary to be vigilant for rare adverse reactions of voriconazole in the population with liver dysfunction, the elderly population, and people with multiple underlying diseases in clinical practice. During medication of voriconazole, close attention should be paid to the occurrence of adverse reactions to avoid life-threatening complications.

    Topics: Aged; Antifungal Agents; Humans; Liver Cirrhosis, Alcoholic; Micafungin; Triazoles; Voriconazole

2023